FDA Approved: UDENYCA — Original Application (Accord BioPharma, Inc.)

View source ↗

Summary

FDA approved UDENYCA (pegfilgrastim-cbqv) as an original biologics license application for reducing the duration of neutropenia in patients with cancer receivin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Chemotherapy-induced Neutropenia
• Neutropenia

Drugs mentioned

• UDENYCA (pegfilgrastim-cbqv)

Snippet

ORIG AP for UDENYCA (PEGFILGRASTIM-CBQV)